Lower Plasma Alcohol With CBD Did Not Improve Performance in a Historical Crossover Study
A historical CBD–alcohol experiment found lower plasma alcohol with the combination but no corresponding improvement on the tested tasks. Concentration and functional performance gave different answers.
The review described both exposure and behavior
The early human review summarizes a crossover study of oral CBD at 200 mg, with and without alcohol. Tests included time production, finger tapping, cancellation and differential aptitude. CBD alone did not affect those measures. Adding CBD to alcohol also did not produce a performance difference compared with alcohol alone, despite significantly lower plasma alcohol in the combination condition.
A laboratory concentration cannot substitute for a task result
The lower plasma measurement did not establish that participants performed better or were less impaired in every respect. The tested tasks also did not supply a complete driving assessment. It would be inaccurate to report only the concentration finding as proof that CBD counteracted alcohol’s functional effects.
The mechanism and practical scope remained limited
The supplied account does not establish why plasma alcohol differed or quantify an individual’s expected change. It concerns a specific historical preparation and acute protocol, not a validated way to reduce intoxication or a legal alcohol-testing rule. The useful inference is that pharmacokinetic and behavioral observations must be interpreted separately. Both belong in an evidence-based account of this experiment.
Related analysis: the broader review findings and limitations.
Research cited
This analysis draws on the supplied review. Individual studies are discussed as summarized there: Zhornitsky and Potvin (2012). Cannabidiol in Humans—The Quest for Therapeutic Targets.
